This search combines search strings from the content search (i.e. "Full Text", "Author", "Title", "Abstract", or "Keywords") with "Article Type" and "Publication Date Range" using the AND operator.
Beilstein J. Nanotechnol. 2024, 15, 569–579, doi:10.3762/bjnano.15.49
Figure 1: Synthesis of the Fe3O4 NCs, CUR-Fe NPs, and CUR-Fe@MnO2 NFs. Figure 1 was drawn using Figdraw (https://www....
Figure 2: Characterization of the nanomaterials. a–c) TEM images of the Fe3O4 NCs, CUR-Fe NPs, and CUR-Fe@MnO2...
Figure 3: a) T1/T2-mapping MR imaging of CUR-Fe@MnO2 NFs at pH 5.0+GSH+H2O2. b) Longitudinal relaxation rate, ...
Figure 4: a) Curves depicting the degradation of MnO2 from CUR-Fe@MnO2 NFs in different environments. b) Curv...
Figure 5: a) Prussian blue staining of Huh-7 cells in the NFs group. b) Prussian blue staining of Huh-7 cells...
Figure 6: a) Toxicity of different concentrations of NFs to Huh-7 cells after heating for 15/20 min. b) Toxic...
Beilstein J. Nanotechnol. 2023, 14, 262–279, doi:10.3762/bjnano.14.24
Figure 1: Application of biomimetic cancer cell membrane-coated nanoparticles in different types of diseases:...
Figure 2: Different roles of the cancer cell membrane. Figure 2 was drawn by Figdraw (https://www.figdraw.com), expor...
Figure 3: Schematic representation of the distribution of cancer cell membrane-encapsulated NPs in a tumor-be...
Figure 4: Characterization of membrane-encapsulated NPs. (A) Gel electrophoresis analysis showed that liver c...
Figure 5: Antitumor efficacy of cancer cell membrane-coated NPs in a hepatocarcinoma mouse model. Hepatoma He...
Figure 6: In vivo MRI assay in transient middle cerebral artery occlusion rats. The infarct area of rats trea...
Figure 7: Distribution of K7M2 cell membrane-coated hollow manganese dioxide nanoparticles loaded with alendr...
Beilstein J. Nanotechnol. 2020, 11, 1000–1009, doi:10.3762/bjnano.11.84
Figure 1: Schematic illustration of FGDA nanocube synthesis. Briefly, a mixture containing sodium oleate, wat...
Figure 2: TEM and HRTEM images of FGOA (a) and FGDA (b, c) nanocubes with their respective size distributions...
Figure 3: (a) T1-weigted MRI of FGDA nanocubes (top panel) and Gd2O3 nanoparticles (bottom panel). (b) Longit...
Figure 4: (a) CCK-8 cell viability test of L929 cells incubated with FGDA at different Fe concentrations for ...
Figure 5: (a) T1WI and T2WI in vivo images of SD rats before and after intravenous injection of FGDA nanocube...